265 related articles for article (PubMed ID: 31105649)
1. Improving End-User Trust in the Quality of Commercial Probiotic Products.
Jackson SA; Schoeni JL; Vegge C; Pane M; Stahl B; Bradley M; Goldman VS; Burguière P; Atwater JB; Sanders ME
Front Microbiol; 2019; 10():739. PubMed ID: 31105649
[TBL] [Abstract][Full Text] [Related]
2. A Review of Probiotic Ingredient Safety Supporting Monograph Development Conducted by the United States Pharmacopeia (USP).
Boyte ME; Akhtar N; Koshy B; Roe AL
J Diet Suppl; 2024 Feb; ():1-39. PubMed ID: 38356247
[TBL] [Abstract][Full Text] [Related]
3. Emerging issues in probiotic safety: 2023 perspectives.
Merenstein D; Pot B; Leyer G; Ouwehand AC; Preidis GA; Elkins CA; Hill C; Lewis ZT; Shane AL; Zmora N; Petrova MI; Collado MC; Morelli L; Montoya GA; Szajewska H; Tancredi DJ; Sanders ME
Gut Microbes; 2023; 15(1):2185034. PubMed ID: 36919522
[TBL] [Abstract][Full Text] [Related]
4. Probiotic use in at-risk populations.
Sanders ME; Merenstein DJ; Ouwehand AC; Reid G; Salminen S; Cabana MD; Paraskevakos G; Leyer G
J Am Pharm Assoc (2003); 2016; 56(6):680-686. PubMed ID: 27836128
[TBL] [Abstract][Full Text] [Related]
5. Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide.
Mazzantini D; Calvigioni M; Celandroni F; Lupetti A; Ghelardi E
Front Microbiol; 2021; 12():693973. PubMed ID: 34354690
[TBL] [Abstract][Full Text] [Related]
6. Considerations for determining safety of probiotics: A USP perspective.
Roe AL; Boyte ME; Elkins CA; Goldman VS; Heimbach J; Madden E; Oketch-Rabah H; Sanders ME; Sirois J; Smith A
Regul Toxicol Pharmacol; 2022 Dec; 136():105266. PubMed ID: 36206977
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-Based Tools and Software in Clinical Research: A New Emerging Area.
Bansal P; Arora M; Gupta V; Maithani M
Methods Mol Biol; 2019; 1939():215-230. PubMed ID: 30848464
[TBL] [Abstract][Full Text] [Related]
8. Compositional Quality and Possible Gastrointestinal Performance of Marketed Probiotic Supplements.
Aziz G; Zaidi A; Tariq M
Probiotics Antimicrob Proteins; 2022 Apr; 14(2):288-312. PubMed ID: 35199309
[TBL] [Abstract][Full Text] [Related]
9. Specific cultivation-independent enumeration of viable cells in probiotic products using a combination of fluorescence
Snaidr L; Mühlhahn P; Beimfohr C; Kreuzer C; Richly C; Snaidr J
Front Microbiol; 2024; 15():1410709. PubMed ID: 38933029
[TBL] [Abstract][Full Text] [Related]
10. Authenticity of probiotic foods and dietary supplements: A pivotal issue to address.
Fusco V; Fanelli F; Chieffi D
Crit Rev Food Sci Nutr; 2022; 62(25):6854-6871. PubMed ID: 33819118
[TBL] [Abstract][Full Text] [Related]
11. The Development of High-Quality Multispecies Probiotic Formulations: From Bench to Market.
Grumet L; Tromp Y; Stiegelbauer V
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824147
[TBL] [Abstract][Full Text] [Related]
12. Culture-Independent Metagenomic Surveillance of Commercially Available Probiotics with High-Throughput Next-Generation Sequencing.
Patro JN; Ramachandran P; Barnaba T; Mammel MK; Lewis JL; Elkins CA
mSphere; 2016; 1(2):. PubMed ID: 27303722
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Microbiological Quality and Resistance to an Artificial Gut Environment of Two Probiotic Formulations.
Mazzantini D; Celandroni F; Calvigioni M; Panattoni A; Labella R; Ghelardi E
Foods; 2021 Nov; 10(11):. PubMed ID: 34829062
[TBL] [Abstract][Full Text] [Related]
15. The power of DNA based methods in probiotic authentication.
Shehata HR; Newmaster SG
Front Microbiol; 2023; 14():1158440. PubMed ID: 37138639
[TBL] [Abstract][Full Text] [Related]
16. New insights in enumeration methodologies of probiotic cells in finished products.
Foglia C; Allesina S; Amoruso A; De Prisco A; Pane M
J Microbiol Methods; 2020 Aug; 175():105993. PubMed ID: 32621828
[TBL] [Abstract][Full Text] [Related]
17. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa.
Brink M; Senekal M; Dicks LM
S Afr Med J; 2005 Feb; 95(2):114-9. PubMed ID: 15751206
[TBL] [Abstract][Full Text] [Related]
18. Validation of probiotic species or subspecies identity in commercial probiotic products using high-resolution PCR method based on large-scale genomic analysis.
Kim E; Kim D; Yang SM; Kim HY
Food Res Int; 2022 Apr; 154():111011. PubMed ID: 35337569
[TBL] [Abstract][Full Text] [Related]
19. Market Assessment and Product Evaluation of Probiotic Containing Dietary Supplements Available in Bangladesh Market.
Begum AA; Jakaria DM; Anisuzzaman SM; Islam M; Mahmud SA
J Pharm (Cairo); 2015; 2015():763796. PubMed ID: 26649229
[TBL] [Abstract][Full Text] [Related]
20. The Probiotic Identity Card: A Novel "Probiogenomics" Approach to Investigate Probiotic Supplements.
Lugli GA; Longhi G; Alessandri G; Mancabelli L; Tarracchini C; Fontana F; Turroni F; Milani C; Di Pierro F; van Sinderen D; Ventura M
Front Microbiol; 2021; 12():790881. PubMed ID: 35126330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
